Theratechnologies presents virologic suppression data from PROMISE-US trial
Theratechnologies (THTX) presented data from a real-world, observational, registry study demonstrating the efficacy and safety of ibalizumab in ...
Physician's Weekly13d
Virologic Suppression and Care Continuity With Telemedicine
The following is a summary of “Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
The New England Journal of Medicine1mon
Virologic and Serologic Studies in a Family Outbreak of Poliomyelitis
THIS is a report of virologic and serologic studies of a family experience with paralytic poliomyelitis that involved all 3 members, father, mother and daughter, and of serologic studies of an ...
Business Insider7d
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
The trial is designed to assess risk factors and predictors of virologic and immunologic response in HTE people with HIV (PWH) and specific sub-populations. Its primary objective is to evaluate the ...
Yahoo Finance7d
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
The trial is designed to assess risk factors and predictors of virologic and immunologic response in HTE people with HIV (PWH) and specific sub-populations. Its primary objective is to evaluate ...